,
, pdf. Toxibase, issue.1, p.25, 1995.
Du hachisch et de l'aliénation mentale: études psychologiques ,
, , p.1845
, Office des Nations Unies contre la drogue et le crime, rapport mondial sur les drogues, 2018.
, Rapport européen sur les drogues. Tendances et évolutions, p.96, 2018.
Les grands traits de la pharmacocinétique du delta-9-tétrahydrocannabinol (THC) ; les nouveaux cannabinoïdes de synthèse ; le cannabis et la sécurité routière ,
, Académie nationale de médecine | Une institution dans son temps, 2014.
Cannabis: usage actuel en population adulte, 2017. ,
La santé des collégiens en France/2014. Données françaises de l'enquête internationale Health Behaviour in School-aged Children (HBSC), Santé publique Fance, p.10, 2014. ,
Les drogues durant les « années Lycées »: résultats de l'enquête ESPAD 2015 en France. tendances [Internet]. sept 206apr ,
, Les drogues à 17 ans: analyse régionale
, Observatoire français des drogues et toxicomanies; 2018 sept, p.54
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish, J Am Chem Soc. 1 avr, vol.86, issue.8, pp.1646-1653, 1964. ,
Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature. 9 août, vol.346, issue.6284, pp.561-565, 1990. ,
CB2 receptors in the brain: role in central immune function, Br J Pharmacol. janv, vol.153, issue.2, pp.240-51, 2008. ,
Endocannabinoid signaling at the periphery: 50 years after THC, Trends Pharmacol Sci. mai, vol.36, issue.5, pp.277-96, 2015. ,
Endocannabinoid signaling in the brain, Science. 26 avr, vol.296, issue.5568, pp.678-82, 2002. ,
Retrograde signaling by endocannabinoids, Curr Opin Neurobiol. juin, vol.12, issue.3, pp.324-354, 2002. ,
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur J Biochem. 15 août, vol.232, issue.1, pp.54-61, 1995. ,
Control of pain initiation by endogenous cannabinoids, Nature. 16 juill, vol.394, issue.6690, pp.277-81, 1998. ,
Differential expression of cannabinoid receptors in the human colon: cannabinoids promote epithelial wound healing, Gastroenterology. août, vol.129, issue.2, pp.437-53, 2005. ,
Cannabinoid CB2 receptors in human brain inflammation, Br J Pharmacol. janv, vol.153, issue.2, pp.277-85, 2008. ,
Cannabinoid receptor as a novel target for the treatment of prostate cancer, Cancer Res. 1 mars, vol.65, issue.5, pp.1635-1676, 2005. ,
Increasing delta-9-tetrahydrocannabinol (?-9-THC) content in herbal cannabis over time: systematic review and meta-analysis, Curr Drug Abuse Rev. mars, vol.5, issue.1, pp.32-40, 2012. ,
Synthetic Cannabis and Acute Ischemic Stroke, J Stroke Cerebrovasc Dis. 1 mai, vol.23, issue.5, pp.1239-1280, 2014. ,
Pharmacokinetics and pharmacodynamics of cannabinoids, Clin Pharmacokinet, vol.42, pp.327-360, 2003. ,
Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis, Psychopharmacology (Berl), vol.74, issue.3, pp.208-220, 1981. ,
Pharmacological and therapeutic secrets of plant and brain (endo)cannabinoids, Med Res Rev. 1 mars, vol.29, issue.2, pp.213-71, 2009. ,
Cannabinoids in medicine: A review of their therapeutic potential, J Ethnopharmacol. 21 avr, vol.105, issue.1, pp.1-25, 2006. ,
Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC, Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol, vol.27, issue.12, pp.1223-1260, 2017. ,
Absorption, Distribution, and Biotransformation of the Cannabinoids ,
, , pp.91-103, 1999.
Cannabis and stroke: is there a link, Postgrad Med J. 1 févr, vol.85, p.80, 1000. ,
Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and women, Clin Pharmacol Ther. sept, vol.34, issue.3, pp.352-63, 1983. ,
Forensic aspects of the metabolism and excretion of cannabinoids following oral ingestion of cannabis resin, J Pharm Pharmacol. mai, vol.36, issue.5, pp.289-94, 1984. ,
, LOI no 99-505 du 18 juin 1999 portant diverses mesures relatives à la sécurité routière et aux infractions sur les agents des exploitants de réseau de transport public de voyageurs. 99-505 juin 18, 1999.
La recherche et le dosage des cannabinoïdes : pourquoi et comment ?, Rev Fr Lab. 1 avr, issue.322, pp.31-34, 2000. ,
High urinary cannabinoids from a hashish body packer, J Anal Toxicol. déc, vol.17, issue.7, pp.439-479, 1993. ,
Saliva Testing for Drugs of Abuse, vol.694, 1993. ,
Le cheveu : un efficace marqueur biologique d'exposition aux xénobiotiques, Ann Biol Clin (Paris). 12 sept, vol.55, issue.5, pp.435-477, 1997. ,
,
, Arch Pediatr Organe Off Soc Francaise Pediatr. mai, vol.18, issue.5, pp.579-88, 2011.
Décès en relation avec l'abus de médicaments et de substances (DRAMES) ,
, , 2016.
Dynamic mapping of human cortical development during childhood through early adulthood, Proc Natl Acad Sci U S A. 25 mai, vol.101, issue.21, pp.8174-8183, 2004. ,
Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia, Prog Neurobiol, vol.92, issue.3, pp.370-85, 2010. ,
The endocannabinoid system as a target for therapeutic drugs, Trends Pharmacol Sci. juin, vol.21, issue.6, pp.218-242, 2000. ,
Drug addiction: the neurobiology of disrupted self-control, Trends Mol Med. déc, vol.12, issue.12, pp.559-66, 2006. ,
Dopamine signals for reward value and risk: basic and recent data, Behav Brain Funct BBF. 23 avr, vol.6, p.24, 2010. ,
Imaging dopamine's role in drug abuse and addiction, Neuropharmacology, vol.56, pp.3-8, 2009. ,
Triadic model of the neurobiology of motivated behavior in adolescence, Psychol Med. mars, vol.36, issue.3, pp.299-312, 2006. ,
Adverse Health Effects of Marijuana Use, N Engl J Med. 5 juin, vol.370, issue.23, pp.2219-2246, 2014. ,
,
, Rev Prat. 15 janv, vol.55, issue.1, pp.30-34, 2005.
Étude des trajectoires d'usage de substances psychoactives chez l'adolescent et l'adulte jeune: Exploration de la théorie de l'escalade ,
, Université Paris Descartes, 2012.
, Conduites addictives chez les adolescents : Usages, prévention et accompagnement
Expertise collective), vol.500, 2014. ,
Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey, Exp Clin Psychopharmacol, vol.2, issue.3, pp.244-68, 1994. ,
Cannabis-induced cognitive and psychiatric disorders, p.20, 2014. ,
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review, Lancet Lond Engl. 28 juill, vol.370, issue.9584, pp.319-347, 2007. ,
People living with psychotic illness in 2010: the second Australian national survey of psychosis, Aust N Z J Psychiatry. août, vol.46, issue.8, pp.735-52, 2012. ,
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study, BMJ, vol.325, issue.7374, pp.1212-1215, 2002. ,
Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study, BMJ, vol.325, issue.7374, p.1199, 2002. ,
An Evidence Based Review of Acute and Long-Term Effects of Cannabis Use on Executive Cognitive Functions, J Addict Med. 1 mars, vol.5, issue.1, pp.1-8, 2011. ,
Cannabis use before age 15 and subsequent executive functioning, Br J Psychiatry. juin, vol.198, issue.06, pp.442-449, 2011. ,
Cannabis use and educational achievement: findings from three Australasian cohort studies, Drug Alcohol Depend. 1 août, vol.110, issue.3, pp.247-53, 2010. ,
Persistent cannabis users show neuropsychological decline from childhood to midlife, Proc Natl Acad Sci, vol.109, issue.40, pp.2657-64, 2012. ,
, Arch Pediatr Organe Off Soc Francaise Pediatr. juin, vol.23, issue.6, pp.619-642, 2016.
Marijuana as a trigger of cardiovascular events: speculation or scientific certainty?, Int J Cardiol. 31 mai, vol.118, issue.2, pp.141-145, 2007. ,
Strokes are possible complications of cannabinoids use, Epilepsy Behav EB, vol.70, pp.355-63, 2017. ,
The Association Between Marijuana Smoking and Lung Cancer: A Systematic Review, Arch Intern Med. 10 juill, vol.166, issue.13, pp.1359-67, 2006. ,
Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. déc, vol.3, issue.12, pp.1398-403, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00428254
A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control CCC, sept, vol.13, issue.7, pp.609-625, 2002. ,
Association between marijuana use and transitional cell carcinoma, Urology. janv, vol.67, issue.1, pp.100-104, 2006. ,
DOI : 10.1016/j.urology.2005.07.005
Marijuana use and cancer incidence (California, United States), Cancer Causes Control CCC. sept, vol.8, issue.5, pp.722-730, 1997. ,
Antiestrogenic effects of marijuana smoke condensate and cannabinoid compounds, Arch Pharm Res. 1 déc, vol.28, issue.12, pp.1365-75, 2005. ,
DOI : 10.1007/bf02977903
A prospective study of the effects of female and male marijuana use on in vitro fertilization (IVF) and gamete intrafallopian transfer (GIFT) outcomes, Am J Obstet Gynecol. févr, vol.194, issue.2, pp.369-76, 2006. ,
Stupéfiants et accidents mortels (projet SAM) -Analyse épidémiologique, p.2011 ,
, Observatoire français des drogues et toxicomanies; 2011 avr, p.166
Portraits dadolescents: enquête épidémiologique multicentrique en milieu scolaire en, 2013. ,
Le développement du repérage des pratiques addictives en médecine générale en France. /data/revues/03987620/v59i5/S0398762011003099, 2011. ,
DOI : 10.1016/j.respe.2011.03.059
,
Consommation de cannabis : conduite à tenir en médecine générale. Datarevues07554982v44i7-8S0755498215000664, 2015. ,
DOI : 10.1016/j.lpm.2014.11.014
,
The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: Reliability, validity and diagnostic cut-off, Drug Alcohol Depend. 9 juin, vol.83, issue.1, pp.90-93, 2006. ,
Optimal scaling of the CAST and of SDS Scale in a national sample of adolescents, Addict Behav. 1 avr, vol.38, issue.4, pp.2060-2067, 2013. ,
The Cannabis Use Problems Identification Test (CUPIT): development, reliability, concurrent and predictive validity among adolescents and adults, Addiction. 1 avr, vol.105, issue.4, pp.615-640, 2010. ,
DOI : 10.1111/j.1360-0443.2009.02859.x
An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R), Drug Alcohol Depend. 1 juill, vol.110, issue.1, pp.137-180, 2010. ,
Stages and processes of self-change of smoking: toward an integrative model of change, J Consult Clin Psychol. juin, vol.51, issue.3, pp.390-395, 1983. ,
Une évolution radicale de la relation thérapeutique, Alcoologie Addictologie, issue.26, p.6, 2004. ,
Comparison of brief versus extended personalised feedback in an online intervention for cannabis users: Short-term findings of a randomised trial, J Subst Abuse Treat, vol.76, pp.43-51, 2017. ,
Motivational interviewing for substance abuse, Cochrane Database Syst Rev. 11 mai, issue.5, p.8063, 2011. ,
Brief interventions for alcohol problems: a review, Addict Abingdon Engl. mars, vol.88, issue.3, pp.315-350, 1993. ,
Le médecin généraliste et la consommation de cannabis des adolescents en France, 2016. ,
Cognitive-Behavioural coping skills therapy manual: a clinical research guide for therapist treating individuals with alcohol abuse and dependence, Natl Inst Alcohol Abuse Alcohol, vol.3, p.116, 1995. ,
The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials, J Subst Abuse Treat, vol.27, issue.3, pp.197-213, 2004. ,
Five outpatient treatment models for adolescent marijuana use: a description of the Cannabis Youth Treatment Interventions, Addict Abingdon Engl. déc, vol.97, issue.1, pp.70-83, 2002. ,
European youth care sites serve different populations of adolescents with cannabis use disorder. Baseline and referral data from the INCANT trial, BMC Psychiatry. 12 juill, vol.11, p.110, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-00663631
Addictions chez l'enfant et l'adolescent. Doin, vol.253, 2014. ,
Mutual attachment, personality, and drug use: pathways from childhood to young adulthood, Genet Soc Gen Psychol Monogr, vol.124, issue.4, pp.492-510, 1998. ,
Multidimensional Family Therapy: Evidence Base for Transdiagnostic Treatment Outcomes, Change Mechanisms, and Implementation in Community Settings, Fam Process, vol.55, issue.3, pp.558-76, 2016. ,
Multidimensional family therapy decreases the rate of externalising behavioural disorder symptoms in cannabis abusing adolescents: outcomes of the INCANT trial, BMC Psychiatry. 31 janv, vol.14, p.26, 2014. ,
Youth-friendly primary-care services: how are we doing and what more needs to be done? The Lancet. 5 mai, vol.369, pp.1565-73, 2007. ,
THE ROLE OF MESOCORTICOLIMBIC DOPAMINE IN REGULATING INTERACTIONS BETWEEN DRUGS OF ABUSE AND SOCIAL BEHAVIOR, Neurosci Biobehav Rev. janv, vol.35, issue.3, pp.498-515, 2011. ,
Screening for adolescent suicidality in primary care: the bullying-insomnia-tobacco-stress test. A population-based pilot study, Early Interv Psychiatry, vol.12, issue.4, pp.637-681, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02128338
Addictions et comorbidités. Paris: Dunod; 2015. 30 p ,
Understanding the addiction cycle: a complex biology with distinct contributions of genotype vs. sex at each stage, Neuroscience, vol.279, pp.168-86, 2014. ,
Interplay between social experiences and the genome: epigenetic consequences for behavior, Adv Genet, vol.77, pp.33-57, 2012. ,
Psychosocial and behavioral factors in early adolescence as predictors of heavy drinking among high school seniors, J Stud Alcohol. juill, vol.61, issue.4, pp.603-609, 2000. ,
Prevention and treatment of drug addiction by environmental enrichment, Prog Neurobiol. déc, vol.92, issue.4, pp.572-92, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00580577
, Committee on the Prevention of Mental Disorders and Substance Abuse Among Children, Research Advances and Promising Interventions. Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities
Impulsivity and Stress Response in Nondependent Smokers (Tobacco Chippers) in Comparison to Heavy Smokers and Nonsmokers, 2009. ,
,
Age at first alcohol use: a risk factor for the development of alcohol disorders, Am J Psychiatry. mai, vol.157, issue.5, pp.745-50, 2000. ,
Immaturities in reward processing and its influence on inhibitory control in adolescence, Cereb Cortex N Y N, vol.20, issue.7, pp.1613-1642, 1991. ,
Australian Institute for Suicide Research and Prevention: selected research readings, Collegian. nov, vol.13, p.243, 2014. ,
, Cannabis repères pour intervenir
A validation of the Cannabis Abuse Screening Test (CAST) using a latent class analysis of the DSM-IV among adolescents, Int J Methods Psychiatr Res. 1 mars, vol.22, issue.1, pp.16-26, 2013. ,
Médecine et hygiène, 'évolution des usages de drogues et des politiques: de l'Europe aux Amériques, 2008. ,
Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study, J Drug Issues. janv, vol.46, issue.1, pp.64-83, 2016. ,
Cannabis withdrawal in adolescent treatment seekers, Drug Alcohol Depend. 9 mai, vol.78, issue.2, pp.205-215, 2005. ,
Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial, Drug Alcohol Depend, vol.156, pp.29-37, 2015. ,
The dose effects of shortterm dronabinol (oral THC) maintenance in daily cannabis users, Drug Alcohol Depend. 1 févr, vol.128, issue.1-2, pp.64-70, 2013. ,
Effects of THC and Lofexidine in a Human Laboratory Model of Marijuana Withdrawal and Relapse, Psychopharmacology (Berl). mars, vol.197, issue.1, pp.157-68, 2008. ,
Dronabinol and Lofexidine for Cannabis Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial, Drug Alcohol Depend. 1 févr, vol.159, pp.53-60, 2016. ,
Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults, Drug Alcohol Depend, vol.112, issue.1-2, pp.39-45, 2010. ,